Skip to main content
. 2020 Jun 26;88(5):739–748. doi: 10.1038/s41390-020-1024-1

Table 3.

MRS metabolite ratios in very preterm and term-born participants.

Metabolite ratio VPT
(n = 54)
TB
(n = 62)
Mean difference (95% CI) pb pc
Mean (SD) Mean (SD) Absolute difference % differencea
Frontal WM
  NAA/Cr 1.64 (0.13) 1.65 (0.14) −0.01 (−0.06, 0.05) −0.33 (−3.39, 2.72) 0.83 0.83
  Cho/Cr 0.32 (0.04) 0.29 (0.04) 0.02 (0.01, 0.04) 7.39 (2.68, 12.10) 0.003 0.01
  Glx/Crd 1.63 (0.19) 1.73 (0.25) −0.10 (−0.02, −0.18) −5.91 (−10.50, −1.32) 0.01 0.03
  mI/Cr 0.55 (0.07) 0.52 (0.08) 0.03 (0.00,0.06) 5.41 (0.18, 10.64) 0.04 0.06
Basal ganglia/thalami (n = 49) (n = 61)
  NAA/Cr 1.35 (0.13) 1.34 (0.12) 0.02 (−0.03, 0.06) 1.25 (−2.29, 4.79) 0.49 0.92
  Cho/Cr 0.23 (0.03) 0.23 (0.03) 0.00 (−0.01, 0.01) −1.13 (−5.23, 2.97) 0.59 0.92
  Glx/Crd 1.42 (0.27) 1.43 (0.25) 0.00 (−0.10, 0.09) −0.33 (−7.17, 6.51) 0.92 0.92
  mI/Cr 0.34 (0.09) 0.34 (0.10) 0.00 (−0.04, 0.03) −0.52 (−11.00, 9.96) 0.92 0.92

VPT very preterm participants, TB term-born participants, CI confidence interval, WM white matter.

aMetabolite ratio difference expressed as a percentage of the mean ratio in the controls for the particular metabolite ratio.

bUnadjusted p values.

cTo account for multiple comparisons, p values were adjusted according to the Benjamini−Hochberg procedure.

dTwo participants (one VPT, one TB) had to be excluded for the analysis of Glx/Cr ratios due to artifacts in the peaks.